ID: ALA1935588

Max Phase: Preclinical

Molecular Formula: C17H15NO3S

Molecular Weight: 313.38

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=S(=O)(c1ccccc1)c1ccc2oc3c(c2c1)CCNC3

Standard InChI:  InChI=1S/C17H15NO3S/c19-22(20,12-4-2-1-3-5-12)13-6-7-16-15(10-13)14-8-9-18-11-17(14)21-16/h1-7,10,18H,8-9,11H2

Standard InChI Key:  ILUMPMYJXUWNQS-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 313.38

Molecular Weight (Monoisotopic): 313.0773

AlogP: 2.91

#Rotatable Bonds: 2

Polar Surface Area: 59.31

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 8.26

CX LogP: 2.61

CX LogD: 1.69

Aromatic Rings: 3

Heavy Atoms: 22

QED Weighted: 0.79

Np Likeness Score: -0.76

References

1. Sundar BG, Bailey TR, Dunn DD, Bacon ER, Salvino JM, Morton GC, Aimone LD, Zeqi H, Mathiasen JR, Dicamillo A, Huffman MJ, McKenna BA, Kopec K, Lu LD, Brown R, Qian J, Angeles T, Connors T, Spais C, Holskin B, Galinis D, Duzic E, Schaffhauser H, Rosse GC..  (2012)  Novel brain penetrant benzofuropiperidine 5-HT₆ receptor antagonists.,  22  (1): [PMID:22153937] [10.1016/j.bmcl.2011.11.050]

Source

Source(1):

• Scientific Literature